Related Experiment Video
Updated: Sep 3, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Preservation of normal gas exchange with hemodilution in patients with pulmonary hypertension
Abstract:
The relationship between the plasma colloid osmotic pressure/pulmonary capillary wedge pressure difference (PCOP-PCWP) and the development of gas exchange abnormalities was examined prior to, during, and after cardiac operations in 13 patients with pulmonary hypertension owing to mitral and/or aortic valvular disease. Alveolar-arterial oxygen tension gradient [P(A-a)DO2] and pulmonary shunt fraction (Qs/Qt) were used as indices of gas exchange impairment owing to accumulated lung water. During the baseline period, PCOP-PCWP was -8.5 +/- 2.6 mm Hg; P(A-a)DO2, 352.5 +/- 30.1 mm Hg; and Qs/Qt, 17.0% +/- 1.5%. There were no significant correlations between PCOP-PCWP and P(A-a)DO2 or Qs/Qt at any time during the study. Thus PCOP-PCWP does not predict susceptibility to lung water accumulation reliably in patients with pulmonary hypertension, and other protective factors may contribute to unimpaired gas exchange, even in the setting of profound hemodilution and low PCOP.
More Related Videos
08:12Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
09:47Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
Published on: June 14, 2024
Related Concept Videos
Respiration and Gaseous Exchange
Respiration involves the exchange of gases, especially oxygen (O2) and carbon dioxide (CO2), between the alveoli and body cells, a process facilitated by blood circulation. As a result, the cardiovascular system, which involves the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Edema II: Pathophysiology